Marpai (MRAI) Competitors $1.64 +0.19 (+13.10%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends MRAI vs. SGRP, PIII, XGN, ENZ, BNR, CCM, OPGN, PMD, TOI, and BRTXShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include SPAR Group (SGRP), P3 Health Partners (PIII), Exagen (XGN), Enzo Biochem (ENZ), Burning Rock Biotech (BNR), Concord Medical Services (CCM), OpGen (OPGN), Psychemedics (PMD), Oncology Institute (TOI), and BioRestorative Therapies (BRTX). Marpai vs. SPAR Group P3 Health Partners Exagen Enzo Biochem Burning Rock Biotech Concord Medical Services OpGen Psychemedics Oncology Institute BioRestorative Therapies Marpai (NASDAQ:MRAI) and SPAR Group (NASDAQ:SGRP) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership. Which has more volatility & risk, MRAI or SGRP? Marpai has a beta of 4.69, indicating that its share price is 369% more volatile than the S&P 500. Comparatively, SPAR Group has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Is MRAI or SGRP more profitable? SPAR Group has a net margin of 5.35% compared to Marpai's net margin of -85.70%. SPAR Group's return on equity of 10.88% beat Marpai's return on equity.Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% SPAR Group 5.35%10.88%4.60% Does the media refer more to MRAI or SGRP? In the previous week, Marpai had 3 more articles in the media than SPAR Group. MarketBeat recorded 3 mentions for Marpai and 0 mentions for SPAR Group. SPAR Group's average media sentiment score of 1.00 beat Marpai's score of 0.30 indicating that SPAR Group is being referred to more favorably in the news media. Company Overall Sentiment Marpai Neutral SPAR Group Positive Which has preferable earnings & valuation, MRAI or SGRP? SPAR Group has higher revenue and earnings than Marpai. Marpai is trading at a lower price-to-earnings ratio than SPAR Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.65-$28.75M-$2.64-0.62SPAR Group$262.75M0.20$3.90M$0.534.19 Does the MarketBeat Community prefer MRAI or SGRP? SPAR Group received 127 more outperform votes than Marpai when rated by MarketBeat users. Likewise, 70.49% of users gave SPAR Group an outperform vote while only 66.67% of users gave Marpai an outperform vote. CompanyUnderperformOutperformMarpaiOutperform Votes266.67% Underperform Votes133.33% SPAR GroupOutperform Votes12970.49% Underperform Votes5429.51% Do insiders & institutionals believe in MRAI or SGRP? 49.8% of Marpai shares are owned by institutional investors. Comparatively, 9.6% of SPAR Group shares are owned by institutional investors. 61.3% of Marpai shares are owned by insiders. Comparatively, 59.7% of SPAR Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts recommend MRAI or SGRP? Marpai presently has a consensus price target of $6.00, suggesting a potential upside of 265.85%. Given Marpai's stronger consensus rating and higher possible upside, research analysts plainly believe Marpai is more favorable than SPAR Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marpai 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00SPAR Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummarySPAR Group beats Marpai on 10 of the 18 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$22.53M$2.02B$6.92B$8.82BDividend YieldN/A6.93%2.92%4.07%P/E Ratio-0.6215.6245.6017.66Price / Sales0.655.76203.5874.22Price / CashN/A11.3624.3332.53Price / Book-0.953.275.084.68Net Income-$28.75M$69.56M$121.19M$226.08M7 Day Performance38.98%-0.03%-1.13%-2.03%1 Month Performance196.16%2.88%8.15%0.07%1 Year Performance80.22%-12.30%29.53%24.61% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpai1.994 of 5 stars$1.64+13.1%$6.00+265.9%+80.2%$19.92M$37.15M-0.62150SGRPSPAR Group3.9097 of 5 stars$2.22+2.8%N/A+135.1%$50.65M$262.75M4.3524,288Positive NewsHigh Trading VolumePIIIP3 Health Partners3.2506 of 5 stars$0.20-4.7%$2.38+1,065.4%-82.9%$75.44M$1.27B0.00500Analyst ForecastAnalyst RevisionHigh Trading VolumeXGNExagen4.7894 of 5 stars$4.20+19.0%$7.00+66.7%+169.2%$62.26M$52.55M0.00220Analyst RevisionGap UpHigh Trading VolumeENZEnzo Biochem0.5149 of 5 stars$0.99-2.0%N/A-22.3%$52.77M$31.91M0.00520BNRBurning Rock BiotechN/A$4.64+0.9%N/A-48.5%$47.51M$75.70M-0.971,390CCMConcord Medical Services0.3558 of 5 stars$4.35-3.3%N/A-58.6%$18.88M$75.69M0.00970Gap UpOPGNOpGenN/A$1.99+1.5%N/A-55.8%$16.40M$3.42M0.00100News CoveragePMDPsychemedics0.5329 of 5 stars$2.33-0.4%N/A+11.0%$13.79M$22.10M0.00140TOIOncology Institute2.3174 of 5 stars$0.13-27.4%$2.50+1,791.1%-94.1%$13.59M$324.24M0.00660Gap DownHigh Trading VolumeBRTXBioRestorative Therapies3.7583 of 5 stars$1.40+0.7%$18.00+1,185.7%-22.2%$9.69M$150,000.00-0.917Analyst RevisionNews CoverageGap Up Related Companies and Tools Related Companies SPAR Group Competitors P3 Health Partners Competitors Exagen Competitors Enzo Biochem Competitors Burning Rock Biotech Competitors Concord Medical Services Competitors OpGen Competitors Psychemedics Competitors Oncology Institute Competitors BioRestorative Therapies Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MRAI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
